<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04591847</url>
  </required_header>
  <id_info>
    <org_study_id>121/2563</org_study_id>
    <nct_id>NCT04591847</nct_id>
  </id_info>
  <brief_title>Pregnancy Outcome and Vitamin D Level Among Vitamin D Supplementation During Pregnancy</brief_title>
  <official_title>Pregnancy Outcomes and Vitamin D Level Among Vitamin D Supplementation During Pregnancy : A Double-blind Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rajavithi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rajavithi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compared pregnancy outcome (Serum vitamin D level in mother and infant , preeclampsia&#xD;
      rate, preterm birth rate, Infant birth weight, Infant length , APGAR score) between pregnant&#xD;
      women who were given vitamin D supplementation and pregnant women who were given placebo&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 19, 2020</start_date>
  <completion_date type="Actual">August 31, 2021</completion_date>
  <primary_completion_date type="Actual">July 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum 25-OH vitamin D level in pregnant women</measure>
    <time_frame>At delivery time</time_frame>
    <description>measure in nmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum 25-OH vitamin D level in umbilicalcord blood</measure>
    <time_frame>At delivery time</time_frame>
    <description>measure in nmol/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Preeclampsia</measure>
    <time_frame>During pregnancy until delivery</time_frame>
    <description>Measure by clinical and laboratory of preeclampsia&#xD;
à¹‰high blood pressure ( &gt;= 140/90 mmHg) with proteinuria (UPCI &gt; 0.3 mg/dL or Urine protein 24 hours &gt; 300 mg) or in absence of proteinuria with new onset of any of the following&#xD;
thrombocytopenia : Platelet count less than 100,000 x 10^9 /L&#xD;
Serum creatinine &gt; 1.1 mg/dL or doubling of the serum creatinine&#xD;
Elevated liver transaminases to twice normal&#xD;
Pulmonary edema&#xD;
New onset headache unresponsive to medication&#xD;
Visual symptom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preterm birth</measure>
    <time_frame>At delivery time</time_frame>
    <description>Delivery before GA 37 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant APGAR score</measure>
    <time_frame>At delivery time</time_frame>
    <description>Measure at delivery time score 10/10&#xD;
Appearance : Cyanotic, pale all over = 0 , Peripheral cyanotic only = 1 , Pink = 2 Pulse : 0 bpm = 0 , &lt;100 = 1, 100-140 = 2 Grimace : no response to stimulation = 0 , Grimace(facial movement ,weak cry) = 1 Cry when stimulated = 2 Activity (tone) : floppy = 0 , Some flexion = 1 , Well flexed and resisting extension = 2 Respiration : Apnoeic = 0 , Slow irregular = 1 , Strong cry = 2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant birth weight</measure>
    <time_frame>At delivery time</time_frame>
    <description>measure in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant length</measure>
    <time_frame>At delivery time</time_frame>
    <description>measure in centimeters</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Pregnancy Outcome Among Vitamin D Supplementation During Pregnancy</condition>
  <arm_group>
    <arm_group_label>Vitamin D supplemented group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D2 20000 IU 1 tab oral weekly start at GA 18 -22 weeks until delivery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placebo drug (Appearance same as Vitamin D2) 1 tab oral weekly start at GA 18 -22 weeks until delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D 2</intervention_name>
    <description>Vitamin D2 20000IU 1 tab oral weekly</description>
    <arm_group_label>Vitamin D supplemented group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo drug</intervention_name>
    <description>Placebo drugs 1 tab oral weekly</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Thai female&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Age at 18 years old or more&#xD;
&#xD;
          -  Gestational age at 18-22 weeks&#xD;
&#xD;
          -  Accept to enroll&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women who not planned to delivery at Rajavithi hospital&#xD;
&#xD;
          -  Abnormal kidney function&#xD;
&#xD;
          -  Use antiepileptic drugs , or vitamin D supplementation&#xD;
&#xD;
          -  Allergy to vitamin D&#xD;
&#xD;
          -  Who were diagnosed as vitamin D deficiency&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rajavithi hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 14, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>September 10, 2021</last_update_submitted>
  <last_update_submitted_qc>September 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>25-hydroxyvitamin D</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Infant</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

